GENITOURINARY SYNDROME OF MENOPAUSE (GSM)
Clinical trials for GENITOURINARY SYNDROME OF MENOPAUSE (GSM) explained in plain language.
Never miss a new study
Get alerted when new GENITOURINARY SYNDROME OF MENOPAUSE (GSM) trials appear
Sign up with your email to follow new studies for GENITOURINARY SYNDROME OF MENOPAUSE (GSM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Menopause moisturizer study pulled before it began
Symptom relief TerminatedThis study was designed to see if adding a hyaluronic acid-based vaginal moisturizer to standard vaginal estrogen therapy provides better relief for menopause-related vaginal symptoms. It planned to include postmenopausal women aged 45 and older who had not used these treatments …
Matched conditions: GENITOURINARY SYNDROME OF MENOPAUSE (GSM)
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated May 26, 2026 03:29 UTC
-
New hope for cancer survivors: personalized relief from menopause symptoms
Symptom relief OngoingThis study tests a personalized, non-hormonal approach to treat genitourinary syndrome of menopause (GSM) in 65 women who have completed cancer treatment. GSM causes vaginal dryness, pain, and urinary discomfort. The goal is to see if tailored treatments can ease these symptoms a…
Matched conditions: GENITOURINARY SYNDROME OF MENOPAUSE (GSM)
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Symptom relief
Last updated May 26, 2026 03:14 UTC